Induction of anti-tumor activity following autologous stem cell transplantation: immunotherapeutic implications.
C.U.C.A.I.B.A., Ministry of Health, Buenos Aires, Argentina.
G H
GH
Marin
M E
ME
Menna
M I
MI
Bergna
J
J
Malacalza
C
C
Martin
M C
MC
Mendez
G
G
Klein
L
L
Montero-Labat
M A
MA
Gil
S
S
Saba
L
L
Gardenal
E
E
Mansilla
S
S
Orlando
C
C
Canepa
G
G
Piccinelli
D000208:Acute Disease; D000328:Adult; D005260:Female; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007111:Immunity, Cellular; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000628:therapy; D007951:Leukemia, Myeloid / Q000276:immunology / Q000628:therapy; D008223:Lymphoma / Q000276:immunology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy; D011446:Prospective Studies; D013601:T-Lymphocytes / Q000276:immunology*; D014182:Transplantation, Autologous